These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 21215348)

  • 1. IL-5 release of CD4+ non-effector lymphocytes is increased in COPD--modulating effects of moxifloxacin and dexamethasone.
    Schild K; Knobloch J; Yakin Y; Jungck D; Urban K; Müller K; Koch A
    Int Immunopharmacol; 2011 Apr; 11(4):444-8. PubMed ID: 21215348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of lipoteichoic acid on IL-2 and IL-5 release from T lymphocytes in asthma and COPD.
    Mat Z; Grensemann B; Yakin Y; Knobloch J; Koch A
    Int Immunopharmacol; 2012 Jul; 13(3):284-91. PubMed ID: 22542695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of bacterial endotoxin LPS on expression of INF-gamma and IL-5 in T-lymphocytes from asthmatics.
    Koch A; Knobloch J; Dammhayn C; Raidl M; Ruppert A; Hag H; Rottlaender D; Müller K; Erdmann E
    Clin Immunol; 2007 Nov; 125(2):194-204. PubMed ID: 17884733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic CD4+ T-cell activation is correlated with FEV1 in smokers.
    Glader P; von Wachenfeldt K; Löfdahl CG
    Respir Med; 2006 Jun; 100(6):1088-93. PubMed ID: 16246539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interleukin-17 expression and significance in normal lung function smokers and chronic obstructive pulmonary disease patients].
    Zhang JQ; Lao QF; Chu SY; Bai J; Zhong XN
    Zhonghua Yi Xue Za Zhi; 2010 May; 90(20):1431-5. PubMed ID: 20646637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of CD4+IL-17+ cells in the lung tissue of patients with stable chronic obstructive pulmonary disease (COPD) and smokers.
    Zhang J; Chu S; Zhong X; Lao Q; He Z; Liang Y
    Int Immunopharmacol; 2013 Jan; 15(1):58-66. PubMed ID: 23127823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased proportion of Fas positive CD8+ cells in peripheral blood of patients with COPD.
    Domagała-Kulawik J; Hoser G; Dabrowska M; Chazan R
    Respir Med; 2007 Jun; 101(6):1338-43. PubMed ID: 17118637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of smoking cessation on airway T lymphocyte subsets in COPD.
    Roos-Engstrand E; Ekstrand-Hammarström B; Pourazar J; Behndig AF; Bucht A; Blomberg A
    COPD; 2009 Apr; 6(2):112-20. PubMed ID: 19378224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol impairs the release of steroid-resistant cytokines from bacterial endotoxin-exposed alveolar macrophages in chronic obstructive pulmonary disease.
    Knobloch J; Hag H; Jungck D; Urban K; Koch A
    Basic Clin Pharmacol Toxicol; 2011 Aug; 109(2):138-43. PubMed ID: 21447053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of surface antigens in blood CD8+ T-lymphocytes in COPD: effects of smoking.
    Koch A; Gaczkowski M; Sturton G; Staib P; Schinköthe T; Klein E; Rubbert A; Bacon K; Wassermann K; Erdmann E
    Eur Respir J; 2007 Jan; 29(1):42-50. PubMed ID: 17050556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The T-helper cell type 1 immune response to gram-negative bacterial infections is impaired in COPD.
    Knobloch J; Schild K; Jungck D; Urban K; Müller K; Schweda EK; Rupp J; Koch A
    Am J Respir Crit Care Med; 2011 Jan; 183(2):204-14. PubMed ID: 20709824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in sputum T-lymphocyte subpopulations at the onset of severe exacerbations of chronic obstructive pulmonary disease.
    Tsoumakidou M; Tzanakis N; Chrysofakis G; Kyriakou D; Siafakas NM
    Respir Med; 2005 May; 99(5):572-9. PubMed ID: 15823454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic characterisation of T-lymphocytes in COPD: abnormal CD4+CD25+ regulatory T-lymphocyte response to tobacco smoking.
    Barceló B; Pons J; Ferrer JM; Sauleda J; Fuster A; Agustí AG
    Eur Respir J; 2008 Mar; 31(3):555-62. PubMed ID: 18057064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systemic defect in Toll-like receptor 4 signaling increases lipopolysaccharide-induced suppression of IL-2-dependent T-cell proliferation in COPD.
    Knobloch J; Chikosi SJ; Yanik S; Rupp J; Jungck D; Koch A
    Am J Physiol Lung Cell Mol Physiol; 2016 Jan; 310(1):L24-39. PubMed ID: 26498252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The changes and significance of interleukin-16 and CXC chemokine receptor 3 expression in pulmonary artery of smokers with chronic obstructive pulmonary disease].
    Wan P; Zhong XN; He ZY; Zhang JQ; Liu GN; Lao QF
    Zhonghua Nei Ke Za Zhi; 2009 Oct; 48(10):841-5. PubMed ID: 20079227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between peripheral blood T-cell profiles and clinical and inflammatory parameters in stable COPD.
    Shirai T; Suda T; Inui N; Chida K
    Allergol Int; 2010 Mar; 59(1):75-82. PubMed ID: 20035145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simvastatin requires activation in accessory cells to modulate T-cell responses in asthma and COPD.
    Knobloch J; Yakin Y; Körber S; Grensemann B; Bendella Z; Boyaci N; Gallert WJ; Yanik SD; Jungck D; Koch A
    Eur J Pharmacol; 2016 Oct; 788():294-305. PubMed ID: 27343379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocytes, chronic bronchitis and chronic obstructive pulmonary disease.
    Jeffery PK
    Novartis Found Symp; 2001; 234():149-61; discussion 161-8. PubMed ID: 11199094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotactic mediators of Th1 T-cell trafficking in smokers and COPD patients.
    Brozyna S; Ahern J; Hodge G; Nairn J; Holmes M; Reynolds PN; Hodge S
    COPD; 2009 Feb; 6(1):4-16. PubMed ID: 19229703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced apoptosis of CD8+ T-lymphocytes in the airways of smokers with mild/moderate COPD.
    Siena L; Gjomarkaj M; Elliot J; Pace E; Bruno A; Baraldo S; Saetta M; Bonsignore MR; James A
    Respir Med; 2011 Oct; 105(10):1491-500. PubMed ID: 21612902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.